Julian E. Fuchs

A selective and orally bioavailable VHL-recruiting PROTAC achieves SMARCA2 degradation in vivo

Christiane Kofink, Nicole Trainor, Barbara Mair et al. · Nature Communications · 2022 · 206 citations · Full text

Medicine, Molecular Biology, Oncology +15

Heteroaromatic π-Stacking Energy Landscapes

Roland G. Huber, Michael A. Margreiter, Julian E. Fuchs et al. · Journal of Chemical Information and Modeling · 2014 · 196 citations · Full text

Pharmacy, Chemistry, Medicinal Chemistry +13

DPPC-cholesterol phase diagram using coarse-grained Molecular Dynamics simulations

Wang Yin, Paraskevi Gkeka, Julian E. Fuchs et al. · Biochimica et Biophysica Acta (BBA) - Biomembranes · 2016 · 150 citations

Natural Sciences, Biochemistry, Chemistry +14

Start Selective and Rigidify: The Discovery Path toward a Next Generation of EGFR Tyrosine Kinase Inhibitors

Harald Engelhardt, Dietrich Böse, Mark Petronczki et al. · Journal of Medicinal Chemistry · 2019 · 145 citations · Full text

Medicine, Oncology, Pharmacology +17

Synthesis of 1,2-benzisoxazole tethered 1,2,3-triazoles that exhibit anticancer activity in acute myeloid leukemia cell lines by inhibiting histone deacetylases, and inducing p21 and tubulin acetylation

N. Ashwini, Manoj Garg, Chakrabhavi Dhananjaya Mohan et al. · Bioorganic & Medicinal Chemistry · 2015 · 136 citations

Medicine, Medicinal Chemistry, Oncology +14